Bayesian Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bayesian Capital Management’s Portfolio BCRX Stock Details BCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell
2024 Q4	$193K	Buy
2024 Q3	–	Sell
2024 Q2	$267K	Buy
2024 Q1	–	Sell
2023 Q4	$363K	Sell
2023 Q3	$557K	Buy
2023 Q2	$106K	Buy
2022 Q4	–	Sell
2022 Q3	$510K	Buy
2020 Q2	–	Sell
2020 Q1	$54K	Buy